Corporate Tech Investors

MedImmune Ventures

MedImmune Ventures is a corporate entity that makes strategic investments in startup ventures that can advance its organizational interests.

Venture Investor Overview

Contact Information

Background Information

Overview

MedImmune Ventures, Inc. is a wholly owned venture capital subsidiary of MedImmune, Inc., a subsidiary of AstraZeneca. It was created in 2002 to leverage the company's expertise in discovering, developing and commercializing biotechnology products, as well as its financial resources, to transform new ideas in biotechnology into successful products and companies.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

4/26/2018

Transaction History

Our records indicate that MedImmune Ventures invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Managing Director

Ronald Laufer

        

Managing Director

Samuel Wu

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

MedImmune Ventures has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Medidata Solutions | Medipower

Share this article

About Our Database of Corporate Tech Investors

This corporate tech investor profile is powered by VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary